Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01988090 · ClinicalTrials.gov registry record · Phase 2
High Dose Vitamin D vs Standard Dose Vitamin D Study
A Phase 2 study, sponsored by Mothaffar Rimawi.
- Terminated
- Registry status
- Phase 2
- Development phase
- 93
- Enrollment target
NCT01988090: Clinical Trial Phase 2 study, sponsored by Mothaffar Rimawi.
NCT01988090 is a Phase 2 study that was terminated before completion, run by Mothaffar Rimawi. The registered enrollment target is 93 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01988090, a Phase 2 study, was terminated before completion, sponsored by Mothaffar Rimawi.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 93 participants
- Enrollment target
Study Summary
This study is being done to look at the difference, if there is a difference between two different doses of Vitamin D and the reduction of joint/muscle pain (arthralgia)that is caused by taking anti-estrogen medications (aromatase inhibitors) by breast cancer patients. The investigators hope to learn if taking a higher dose of Vitamin D is a good way to prevent aromatase inhibitor arthralgia (AIA).
Interventions
- DRUG 800 IU Vitamin D Supplement
- DRUG 50,000 IU Vitamin D supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2013-12 |
| Est. Completion | 2018-12-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01988090
The ClinicalTrials.gov registry entry for NCT01988090 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mothaffar Rimawi, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 800 IU Vitamin D Supplement is the first listed.
NCT01988090 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01988090 about?
NCT01988090 is a clinical study titled "High Dose Vitamin D vs Standard Dose Vitamin D Study". This study is being done to look at the difference, if there is a difference between two different doses of Vitamin D and the reduction of joint/muscle pain (arthralgia)that is caused by taking anti-estrogen medications (aromatase inhibitors) by breast cancer patients. The investigators hope to lear...
What is the current status of trial NCT01988090?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 93 participants. The study started on 2013-12. Estimated completion is 2018-12-10.
What interventions are being tested in trial NCT01988090?
The interventions under investigation include: 800 IU Vitamin D Supplement (DRUG), 50,000 IU Vitamin D supplement (DRUG).
Who is sponsoring clinical trial NCT01988090?
This trial is sponsored by Mothaffar Rimawi, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.